What are the steps to plan a Percutaneous Coronary Intervention (PCI) case, including guidewire and balloon selection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Planning a Percutaneous Coronary Intervention (PCI) Case: A Systematic Approach

PCI planning requires a systematic approach that includes careful assessment of coronary anatomy, lesion characteristics, and appropriate selection of equipment based on established guidelines. The following steps will guide you through planning and executing a successful PCI procedure.

Pre-Procedure Planning

1. Patient and Lesion Assessment

  • Review coronary angiography to determine:
    • Target vessel and lesion location
    • Lesion characteristics (length, calcification, tortuosity, bifurcation)
    • Reference vessel diameter
    • Presence of thrombus
    • Collateral circulation
  • Use IVUS (Intravascular Ultrasound) when appropriate for:
    • Assessment of lesion characteristics and vessel dimensions to select optimal revascularization device 1
    • Evaluation of coronary obstruction at locations difficult to image by angiography 1
    • Determination of plaque distribution for complex lesions 1

2. Access Site Selection

  • Radial access is recommended as the standard approach unless there are overriding procedural considerations 1
  • Consider femoral access for complex cases requiring larger guide catheters or when radial access is not feasible

Procedural Equipment Selection

1. Guide Catheter Selection

  • Choose based on:
    • Target vessel (e.g., JL for left system, JR for right coronary artery)
    • Required support (e.g., EBU, XB, or AL for increased support)
    • Size: 6F is standard for most cases, 7-8F for complex procedures requiring larger equipment

2. Guidewire Selection

  • Initial wire choice:
    • Workhorse wire (0.014" floppy-tipped wire) for straightforward lesions
    • Examples: BMW, Runthrough, Prowater
  • Specialized wires based on lesion characteristics:
    • Tortuous vessels: Hydrophilic coated wires (e.g., Whisper, Fielder)
    • Calcified lesions: Stiffer wires with good torque control (e.g., Grand Slam, Iron Man)
    • Chronic total occlusions (CTOs): Specialized CTO wires with tapered tips (e.g., Fielder XT, Confianza Pro)
    • Consider J-CTO score for CTO cases to determine approach and likelihood of success 2

3. Balloon Selection

  • Pre-dilation balloon:
    • Size: Generally 0.5mm smaller than reference vessel diameter
    • Length: Typically 15-20mm to cover the lesion
    • Specialized balloons for specific scenarios:
      • Calcified lesions: Scoring or cutting balloons 1
      • Non-compliant balloons for resistant lesions
  • Post-dilation balloon (if needed):
    • Non-compliant balloon sized 1:1 with reference vessel diameter
    • Length shorter than stent length to avoid edge dissection

4. Stent Selection

  • Drug-eluting stents (DES) are recommended over bare-metal stents (BMS) for any PCI regardless of:
    • Clinical presentation
    • Lesion type
    • Planned duration of DAPT 1
  • Size: Match to reference vessel diameter (typically 1:1 ratio)
  • Length: Cover entire lesion with 2-3mm margins on each end

Antithrombotic Management

1. Pre-Procedure Antiplatelet Therapy

  • For elective PCI:
    • Aspirin 81-325mg before procedure 1
    • Clopidogrel 600mg loading dose once anatomy is known and decision to proceed with PCI is made 1
  • For ACS patients:
    • Consider more potent P2Y12 inhibitors (prasugrel or ticagrelor) 1

2. Procedural Anticoagulation

  • Unfractionated heparin (UFH) is indicated as standard anticoagulant:
    • Dosage: 70-100 U/kg 1
    • Monitor ACT (activated clotting time) with target 250-300 seconds for procedures without GP IIb/IIIa inhibitors
  • Bivalirudin may be considered as an alternative to reduce bleeding risk 3
  • Fondaparinux should not be used as the sole anticoagulant for PCI 1

Procedural Approach

1. Lesion Preparation

  • Cross lesion with appropriate guidewire
  • Pre-dilate lesion if:
    • Severe stenosis
    • Calcified lesion
    • CTO after recanalization
  • Consider specialized techniques for complex lesions:
    • Rotational atherectomy for heavily calcified lesions 1
    • Cutting balloon for in-stent restenosis or ostial lesions 1

2. Stent Deployment

  • Position stent precisely to cover entire lesion
  • Deploy at appropriate pressure (usually 10-14 atm)
  • Consider IVUS to assess stent apposition and expansion 1

3. Post-Stent Optimization

  • Post-dilate with non-compliant balloon if:
    • Residual stenosis
    • Suboptimal stent expansion
    • IVUS shows incomplete stent apposition
  • Final angiography in multiple views to confirm:
    • Adequate stent expansion
    • No edge dissection
    • TIMI 3 flow

Special Considerations

1. Bifurcation Lesions

  • Stent implantation in the main vessel only, followed by provisional balloon angioplasty with or without stenting of the side branch, is recommended 1
  • Consider two-stent techniques (T-stenting, Culotte, DK-crush) for large side branches with significant disease

2. Chronic Total Occlusions

  • Requires specialized equipment and techniques
  • Consider antegrade vs. retrograde approach based on lesion characteristics
  • Use specialized CTO wires and microcatheters for support

3. Calcified Lesions

  • Consider IVUS to establish presence and distribution of calcium 1
  • Use rotational atherectomy for heavily calcified lesions that cannot be crossed or dilated with conventional balloon angioplasty 1

4. Cardiogenic Shock

  • Consider hemodynamic support devices for high-risk patients 1
  • Primary PCI should be performed for patients with cardiogenic shock due to STEMI or NSTE-ACS 1

Post-Procedure Management

1. Antiplatelet Therapy

  • DAPT (Dual Antiplatelet Therapy):
    • Aspirin (75-100mg daily) indefinitely 1
    • P2Y12 inhibitor (clopidogrel, prasugrel, or ticagrelor) for at least 6-12 months depending on clinical scenario 1

2. Follow-up

  • Monitor for complications:
    • Access site complications (bleeding, hematoma, pseudoaneurysm) 4
    • Stent thrombosis (acute, subacute, late)
    • Restenosis (typically 1-8 months post-procedure) 4

Common Pitfalls to Avoid

  1. Inadequate lesion preparation - Particularly important for calcified or complex lesions
  2. Inappropriate stent sizing - Undersized stents increase restenosis risk; oversized stents risk dissection or perforation
  3. Geographic miss - Failure to cover the entire lesion with the stent
  4. Edge dissections - Can lead to acute vessel closure if not recognized and treated
  5. Premature discontinuation of DAPT - Can lead to catastrophic stent thrombosis 5
  6. Contrast nephropathy - Minimize contrast volume and ensure adequate hydration 4

By following this systematic approach to PCI planning and execution, you can optimize procedural success and minimize complications, ultimately improving patient outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.